Cocrystal Pharma Inc

General ticker "COCP" information:

  • Sector: Health Care
  • Industry: Pharmaceuticals
  • Capitalization: $20.6M

Cocrystal Pharma Inc follows the US Stock Market performance with the rate: 27.1%.

Estimated limits based on current volatility of 7.9%: low 2.45$, high 2.87$

Factors to consider:

  • Price in estimated range
  • Earnings for 6 months up through Q2 are close to our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [1.14$, 3.17$]
  • 2024-12-30 to 2025-12-30 estimated range: [1.39$, 3.45$]

Financial Metrics affecting the COCP estimates:

  • Negative: Non-GAAP EPS, $ of -1.99 <= 0.10
  • Negative: Operating profit margin, % of -100 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -45.77 <= 2.35
  • Negative: Industry operating cash flow per share per price (median), % of -12.63 <= 3.85
  • Positive: Interest expense per share, $ of 0 <= 0

Similar symbols

Short-term COCP quotes

Long-term COCP plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $0.00MM $0.00MM $0.00MM
Operating Expenses $14.22MM $38.83MM $18.56MM
Operating Income $-14.22MM $-38.83MM $-18.56MM
Non-Operating Income $0.04MM $-0.01MM $0.57MM
Interest Expense $0.00MM $0.00MM $0.00MM
R&D Expense $8.79MM $12.39MM $15.17MM
Income(Loss) $-14.19MM $-38.84MM $-17.98MM
Profit(Loss) $-14.19MM $-38.84MM $-17.98MM
Stockholders Equity $77.55MM $39.57MM $26.38MM
Inventory $0.00MM $0.07MM $0.00MM
Assets $79.39MM $40.84MM $31.26MM
Operating Cash Flow $-12.72MM $-21.43MM $-14.67MM
Capital expenditure $0.05MM $0.07MM $0.12MM
Investing Cash Flow $-0.05MM $-0.07MM $-0.12MM
Financing Cash Flow $38.47MM $-0.03MM $3.99MM
Earnings Per Share* $-0.16 $-4.77 $-1.86

* EPS are Split Adjusted, recent splits may be reflected with a delay.